Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: A study in a southern European population

Molecular Biology Reports

Volumn 40, Issue 8, 2013, Pages 4819-4826

  Marques, Inês ^a,b   Teixeira, Ana L ^a,b   Ferreira, Marta ^c   Assis, Joana ^a,b   Lobo, Francisco ^c   Maurício, Joaquina ^c   Medeiros, Rui ^a,b,d,e  

^a Grupo de Oncologia Molecular CI   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^e LPCC   (Portugal)

Author keywords

Caspase 9; Functional polymorphisms; Renal cell carcinoma; Risk; SNP; Survivin

Indexed keywords

CASPASE 9; SURVIVIN;

AGED; APOPTOSIS; ARTICLE; BIRC5 GENE; CANCER RISK; CANCER SUSCEPTIBILITY; CASP9 GENE; DNA POLYMORPHISM; ETHNIC GROUP; EUROPEAN; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PHENOTYPE; POPULATION RESEARCH; RISK FACTOR;

EID: 84881163733     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2578-3     Document Type: Article

References (50)

1. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Lindblad P (2004) Epidemiology of renal cell carcinoma. Scand J Surg 93:88-96
3. Linehan WM, Pinto PA, Srinivasan R, et al. (2007) Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res 13:671s-679s
4. Parker AS, Kosari F, Lohse CM, et al. (2006) High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 107:37-45
5. Jacobson MD, Weil M, Raff MC (1997) Programmed cell death in animal development. Cell 88:347-354
6. Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4:139-163
7. Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3:401-410
8. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921
9. Altieri DC (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581-8589
10. Xu Y, Fang F, Ludewig G, et al. (2004) A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 23:527-537
11. Gazouli M, Tzanakis N, Rallis G, et al. (2009) Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis 24:145-150
12. Qin C, Cao Q, Li P, et al. (2012) Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population. PLoS One 7:e28829
13. Abel F, Sjoberg RM, Ejeskar K, et al. (2002) Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours. Br J Cancer 86:596-604
14. Chowdhury I, Tharakan B, Bhat GK (2008) Caspases: an update. Comp Biochem Physiol B Biochem Mol Biol 151:10-27
15. Shiozaki EN, Chai J, Shi Y (2002) Oligomerization and activation of caspase-9, induced by Apaf-1 CARD. Proc Natl Acad Sci USA 99:4197-4202
16. Ceruti S, Mazzola A, Abbracchio MP (2005) Resistance of human astrocytoma cells to apoptosis induced by mitochondria-damaging agents: possible implications for anticancer therapy. J Pharmacol Exp Ther 314:825-837
17. Yang L, Zhu H, Zhou B, et al. (2009) The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci 54:1021-1028
18. Medeiros R, Vasconcelos A, Costa S, et al. (2003) Steroid hormone genotypes ARStul and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet 141:91-96
19. Schafer ZT, Parrish AB, Wright KM, et al. (2006) Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells. Cancer Res 66:2210-2218
20. Martinelli S, Kostylina G, Niggli V, et al. (2006) Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils. Oncogene 25:6915-6923
21. Altieri DC (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8:61-70
22. Borbely AA, Murvai M, Szarka K, et al. (2007) Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 60:303-306
23. Borges BD, Burbano RR, Harada ML (2010) Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med 11:189-193
24. Upadhyay R, Khurana R, Kumar S, et al. (2011) Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India. Ann Surg Oncol 18:880-887
25. Bayram S, Akkiz H, Bekar A, Akgollu E (2011) The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Cancer Epidemiol 35:555-559
26. Lancaster A, Nelson MP, Meyer D, et al. (2003). PyPop: a software framework for population genomics - analyzing large-scale multi-locus genotype data. Pac Symp Biocomput 514-525
27. Attia J, Thakkinstian A, McElduff P, et al. (2010) Detecting genotyping error using measures of degree of Hardy-Weinberg disequilibrium. Stat Appl Genet Mol Biol 9:article 5
28. Gomes M, Coelho A, Araújo A, et al. (2012) Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of Il-4. Gene 504:111-115
29. Li Y, Wang J, Jiang F, et al. (2012) Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese Han population: a case-control study. BMC Med Genet 13:1
30. Ma F, Zhang H, Huang W, et al. (2011) Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese. PLoS One 6(2):e16748
31. Yazdani N, Sayahpour FA, Haghpanah V, et al. (2012) Survivin gene polymorphism association with papillary thyroid carcinoma. Pathol Res Pract 208:100-103
32. Jaiswal PK, Goel A, Mandhani A, et al. (2012) Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in north Indian cohort. Mol Biol Rep 39:5615-5621
33. Weng CJ, Hsieh YH, Chen MK, et al. (2012) Survivin SNP-carcigonen interactions in oral cancer. J Dent Res 91:358-363
34. Wang X, Huang L, Xu Y, et al. (2012) Association between survivin -31G>C promotor polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet 20:790-795
35. Srivastava K, Srivastava A, Mittal B (2012) Survivin promotor -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta analysis. Mol Biol Rep 39:1509-1516
36. Hoffman WH, Biade S, Zilfou JT, et al. (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247-3257
37. Frew IJ, Krek W (2007) Multitasking by pVHL in tumour suppression. Curr Opin Cell Biol 19:685-690
38. Yu X, Zhang X, Dhakal IB, et al. (2012) Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. BMC Cancer 12:29
39. O'Connor DS, Schechner JS, Adida C, et al. (2000) Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156:393-398
40. Liu JR, Opipari AW, Tan L, et al. (2002) Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res 62:924-931
41. Gerhard MC, Zantl N, Weirich G, et al. (2003) Functional evaluation of the apoptosome in renal cell carcinoma. Br J Cancer 89:2147-2154
42. Ulybina YM, Kuligina E, Mitiushkina NV, et al. (2009) Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett 278:183-191
43. Lou Y, Fang CQ, Li JH (2007) A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:59-62
44. Hlavaty T, Pierik M, Henckaerts L, et al. (2005) Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease. Aliment Pharmacol Ther 22:613-626
45. Ulybina YM, Kuligina ES, Mitiushkina NV, et al. (2011) Distribution of coding apoptotic gene polymorphisms in women with extreme phenotypes of breast cancer predisposition and tolerance. Tumir 97:248-251
46. Lavender NA, Rogers EN, Yeyeodu S, et al. (2012) Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. BMC Med Genomics 5:11
47. Guo C, Ahmad T, Beckly J, et al. (2011) Association of caspase-9 and RNUX3 with inflammatory bowel disease. Tissue Antigens 77:23-29
48. Ferreira, Cravo M, Guerreiro CS, et al. (2010) Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgama apoptotic genes in modulating Crohn's disease activity. Clin Nutr. 29:819-823
49. Wang Q, Li X, Wang L, et al. (2004) Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells. Endocrinology 145:5568-5579
50. Campsall PA, Au NH, Prendiville JS, et al. (2004) Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J Clin Microbiol 42:1409-1413